Leadership. Empowerment. Development.

Friday, October 2, 2020

11:00 AM – 11:05 AM

Welcome Remarks and Conference Overview

11:05 AM – 11:45 AM

Professional Vignettes

Women oncology leaders share their journeys and perspectives on the past and current state of women in healthcare and how they are amplifying women’s voices in oncology

11:45 AM – 12:15 PM

KEYNOTE
Leadership Development

12:15 PM – 1:00 PM

WORKSHOP/PANEL
Leadership Strategies

12:45 PM – 1:00 PM

VIRTUAL EXHIBIT HALL

1:00 PM – 1:45 PM

WORKSHOP/PANEL
Career Advancement in Oncology

  • Setting Yourself Up for Success Workshop
  • Career Transitions Panel

1:45 PM – 2:15 PM

WORKSHOP/PANEL
Health Equity Within Oncology

2:15 PM – 2:30 PM

Award Presentations
Woman Oncologists of the Year and Rising Star

2:30 PM – 3:00 PM

Simultaneous Clinical Panel Discussions

  • Hematologic Malignancies
  • Solid Tumors

3:00 PM

Closing Remarks and Adjourn

Friday, October 2, 2020

*All times listed below are Eastern Time (EST)

11:00 AM – 11:05 AM

Welcome Remarks and Conference Overview

Julie Brahmer, MD
Johns Hopkins Medicine

Nina Shah, MD
University of California San Francisco

Julie Vose, MD, MBA
The University of Nebraska Medical Center

11:05 AM – 11:45 AM

Professional Vignettes

Women oncology leaders share their journeys and perspectives on the past and current state of women in healthcare and how they are amplifying women’s voices in oncology

Julie Gralow, MD
Seattle Cancer Care Alliance

Kristin Hege, MD
Bristol Myers Squibb

Tatiana Prowell, MD
Johns Hopkins Medicine
U.S. Food & Drug Administration

11:45 AM – 12:15 PM

KEYNOTE
Four Competencies That Define Exceptional Leaders

Gary L. Teal
Woodruff Health Sciences Center, Emory University

12:15 PM – 1:00 PM

WORKSHOP/PANEL
Leadership Strategies

Gary L. Teal
Woodruff Health Sciences Center, Emory University

12:45 PM – 1:00 PM

VIRTUAL EXHIBIT HALL

 

1:00 PM – 1:45 PM

WORKSHOP/PANEL
Career Advancement in Oncology

  • Setting Yourself Up for Success Workshop
  • Career Transitions Panel

Nina Shah, MD – Moderator
University of California San Francisco

Linda Bosserman, MD
City of Hope

Nicole Gormley, MD
U.S. Food & Drug Administration

PK Morrow, MD
Amgen

Julie Vose, MD, MBA
The University of Nebraska Medical Center

1:45 PM – 2:15 PM

WORKSHOP/PANEL
Health Equity Within Oncology

Patricia Doykos, PhD
Bristol Myers Squibb

Narjust Duma, MD
University of Wisconsin

Nicole Gormley, MD
U.S. Food & Drug Administration

Dara Richardson-Heron, MD
Pfizer

2:15 PM – 2:30 PM

Award Presentations
Woman Oncologists of the Year and Rising Star

 

2:30 PM – 3:00 PM

Simultaneous Clinical Panel Discussions

  • Hematologic Malignancies

Nina Shah, MD – Moderator
University of California San Francisco

Caitlin Costello, MD
UC San Diego Heath

Carrie Thompson, MD
Mayo Clinic

Julie Vose, MD, MBA
The University of Nebraska Medical Center

Eunice Wang, MD
Roswell Park Comprehensive Cancer Center

 
  • Solid Tumors

Julie Brahmer, MD – Moderator
Johns Hopkins Medicine

Bruna Ferreira Pellini, MD
H. Lee Moffitt Cancer Center

Julie Gralow, MD
Seattle Cancer Care Alliance

Jarushka Naidoo, MBBCh
Johns Hopkins Medicine

Lynn Schuchter, MD
Penn Medicine

Rachna Shroff, MD
The University of Arizona Cancer Center

Shannon Westin, MD, MPH
The University of Texas MD Anderson Cancer Center

3:00 PM

Closing Remarks and Adjourn

Julie Brahmer, MD
Johns Hopkins Medicine

Nina Shah, MD
University of California San Francisco

Julie Vose, MD, MBA
The University of Nebraska Medical Center

A Decade of Advancement: Precision Medicine—From Histology to Molecular Subsets

Bruna Pellini, MD
H. Lee Moffitt Cancer Center

A Decade of Advancement: Harnessing the Patient Immune System

Lynn Schuchter, MD
Penn Medicine

What the Future May Hold: The Microbiome—The Next Target in Cancer Therapy?

Cynthia Sears, MD
Johns Hopkins University

Incorporation of Emerging Treatment Options into Clinical Practice Paradigms:

  • Leukemias
  • Lymphomas
  • Multiple Myeloma

Eunice Wang, MD
Roswell Park Comprehensive Cancer Center

Sonali Smith, MD
The University of Chicago Medicine

Caitlin Costello, MD
UC San Diego Health

Incorporation of Emerging Treatment Options into Clinical Practice Paradigms:

  • Gastrointestinal Cancers
  • Metastatic Breast Cancer

Rachna Shroff, MD, MS
University of Arizona Cancer Center

Julie Gralow, MD
Seattle Cancer Care Alliance

Managing Drug Class Toxicities:

  • PARP Inhibitors in Gynecologic Cancers
  • Checkpoint Inhibitors

Shannon Westin, MD, PhD
The University of Texas
MD Anderson Cancer Center

Jarushka Naidoo, MBBCh
Johns Hopkins Medicine

TKIs in Lung Cancer

Lecia Sequist, MD
Massachusetts General Hospital

CAR T-cell Therapy

Bianca Santomasso, MD, PhD
Memorial Sloan Kettering Cancer Center

Supportive Care for the Female Patient

Anne Katz, MD
Weill Cornell Medicine